JP2025507971A5 - - Google Patents
Info
- Publication number
- JP2025507971A5 JP2025507971A5 JP2024552478A JP2024552478A JP2025507971A5 JP 2025507971 A5 JP2025507971 A5 JP 2025507971A5 JP 2024552478 A JP2024552478 A JP 2024552478A JP 2024552478 A JP2024552478 A JP 2024552478A JP 2025507971 A5 JP2025507971 A5 JP 2025507971A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- independently
- optionally
- methyl
- ring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263316595P | 2022-03-04 | 2022-03-04 | |
| US63/316,595 | 2022-03-04 | ||
| PCT/CA2023/050280 WO2023164775A1 (en) | 2022-03-04 | 2023-03-03 | Radiolabeled compounds targetng the prostate-specific membrane antigen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025507971A JP2025507971A (ja) | 2025-03-21 |
| JP2025507971A5 true JP2025507971A5 (cg-RX-API-DMAC7.html) | 2026-03-10 |
Family
ID=87882764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024552478A Pending JP2025507971A (ja) | 2022-03-04 | 2023-03-03 | 前立腺特異的膜抗原を標的とする放射性標識化合物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250186627A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4486756A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025507971A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023226956A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3244865A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023164775A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3136979A1 (en) | 2019-04-17 | 2020-10-22 | Provincial Health Services Authority | Radiolabelled compounds for diagnosis or treatment of prostate-spe cific membrane antigen-expressing cancer |
| EP4777499A1 (en) * | 2023-09-12 | 2026-07-22 | Shanghai Sinotau Biotech. Co., Ltd | Inhibitors of prostate specific membrane antigen and use thereof |
| EP4590664A1 (en) * | 2023-09-12 | 2025-07-30 | Shanghai Sinotau Biotech. Co., Ltd | Inhibitors of prostate specific membrane antigen and use thereof |
| WO2026002208A1 (zh) * | 2024-06-28 | 2026-01-02 | 思路迪生物医药(上海)有限公司 | 前列腺特异性膜抗原小分子抑制剂及其放射性核素配合物的制备及应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109982998A (zh) * | 2016-11-23 | 2019-07-05 | 癌靶技术有限责任公司 | 白蛋白结合psma抑制剂 |
| CA3060143A1 (en) * | 2017-05-24 | 2018-11-29 | Itm Isotopen Technologien Munchen Ag | Novel psma-binding agents and uses thereof |
| WO2020252598A1 (en) * | 2019-06-21 | 2020-12-24 | Provincial Health Services Authority | Radiolabeled compounds targeting the prostate-specific membrane antigen |
| US11850291B2 (en) * | 2019-10-25 | 2023-12-26 | National Atomic Research Institute | PSMA targeted radiotherapy medicine and preparation method thereof |
-
2023
- 2023-03-03 CA CA3244865A patent/CA3244865A1/en active Pending
- 2023-03-03 AU AU2023226956A patent/AU2023226956A1/en active Pending
- 2023-03-03 WO PCT/CA2023/050280 patent/WO2023164775A1/en not_active Ceased
- 2023-03-03 US US18/842,681 patent/US20250186627A1/en active Pending
- 2023-03-03 JP JP2024552478A patent/JP2025507971A/ja active Pending
- 2023-03-03 EP EP23762646.0A patent/EP4486756A1/en active Pending